5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.14▼ | 2.18▼ | 2.18▼ | 2.20▼ | 2.23▼ |
MA10 | 2.20▼ | 2.25▼ | 2.26▼ | 2.23▼ | 2.10▲ |
MA20 | 2.28▼ | 2.31▼ | 2.32▼ | 2.28▼ | 2.15▼ |
MA50 | 2.23▼ | 2.19▼ | 2.17▼ | 2.11▲ | 2.53▼ |
MA100 | 2.09▲ | 2.08▲ | 2.08▲ | 2.19▼ | 3.30▼ |
MA200 | 2.12▲ | 2.20▼ | 2.25▼ | 2.24▼ | 2.83▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.031▼ | -0.036▼ | -0.038▼ | -0.032▼ | 0.053▲ |
RSI | 39.447▼ | 41.065▼ | 41.505▼ | 43.238▼ | 45.953▼ |
STOCH | 5.833▼ | 8.588▼ | 7.920▼ | 35.559 | 60.145 |
WILL %R | -89.286▼ | -91.195▼ | -91.195▼ | -80.000▼ | -59.155 |
CCI | -86.559 | -133.647▼ | -137.419▼ | -135.112▼ | 47.078 |
Friday, August 08, 2025 04:49 PM
Operating expenses (GAAP) remained flat at $1.9 million. Cash and cash equivalents rose to $12.4 million as of June 30, 2025, reflecting prior successful financing. These 10 stocks could mint the next ...
|
Friday, August 08, 2025 02:36 PM
Research and development expenses were $0.9 million for each of the three months ended June 30, 2025 and June 30, 2024, as an increase in EB06-related expenses for Edesa's planned Phase 2 vitiligo ...
|
Friday, August 08, 2025 01:55 PM
Research and development expenses were $0.9 million for each of the three months ended June 30, 2025 and June 30, 2024, as an increase in EB06-related expenses for Edesa’s planned Phase 2 vitiligo ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/08/25 | 2.15 | 2.15 | 2.07 | 2.12 | 10,600 |
07/08/25 | 2.15 | 2.25 | 2.02 | 2.09 | 40,200 |
06/08/25 | 2.22 | 2.25 | 2.20 | 2.25 | 13,100 |
05/08/25 | 2.35 | 2.35 | 2.20 | 2.26 | 20,900 |
04/08/25 | 2.20 | 2.28 | 2.13 | 2.27 | 9,200 |
01/08/25 | 2.21 | 2.29 | 2.05 | 2.14 | 18,700 |
31/07/25 | 2.26 | 2.38 | 2.23 | 2.25 | 19,688 |
30/07/25 | 2.35 | 2.35 | 2.2006 | 2.27 | 35,684 |
29/07/25 | 2.21 | 2.36 | 2.21 | 2.29 | 29,600 |
28/07/25 | 2.39 | 2.4407 | 2.33 | 2.33 | 7,179 |
|
|
||||
|
|
||||
|
|